Ischemic heart disease Board decisions

The Board granted service connection for congestive heart failure with implanted pacemaker, bradycardia, valvular heart disease, and atrial fibrillation, secondary to the Veteran's service-connected hypertension.

The Board granted service connection for coronary artery disease (CAD) and remanded the claim for chronic obstructive pulmonary disease (COPD).

The Board remands the claim for a heart condition to obtain an addendum opinion from a VA clinician regarding whether the Veteran's current heart condition is related to service, including in-service treatment for hypertension.

The Board denied service connection for GERD, a heart condition, hypertension, a kidney condition, and obstructive sleep apnea as there is no evidence of current disabilities related to these conditions or that they are etiologically linked to the Veteran's military service.

The Board denied the veteran's claims for increased ratings and service connection, dismissing one appeal and remanding others.

The Board denied service connection for various conditions, including diabetes mellitus, type II, coronary artery disease, congestive heart failure, hypertension, asthma/lung disease, vision disability, bilateral plantar fasciitis, leukocytosis, kidney disease/kidney stones, enlarged prostate, sleep apnea, rheumatoid arthritis, lumbar spine disability, right ankle disability, and left ankle disability.

The Board denied service connection for a heart disability, finding no current diagnosis and that the Veteran's reported symptoms were not supported by medical evidence. The issues of service connection for a low back disability and entitlement to TDIU are remanded.

The Board remands the claim for a new medical opinion to address whether the Appellant's heart condition had onset during his period of ACDUTRA service.

The Board denied service connection for hypertension, a heart disorder, and diabetes mellitus as the evidence did not support a positive nexus between these conditions and the Veteran's military service.

The Board denied service connection for various disabilities, including an acquired psychiatric disability, headaches, a back disability, heart disability, and residuals of a stroke, as the evidence did not support a finding that these conditions were related to the Veteran's active service or caused by his service-connected left ear disabilities.

The appeal was denied for service connection of a cervical spine disorder, and several claims were remanded for further development.

The Board granted service connection for coronary artery disease, which is presumed related to in-service exposure to herbicide agents.

The Board granted service connection for a heart disability, to include atherosclerotic cardiovascular disease and coronary artery disease as secondary to the Veteran's service-connected disabilities. The claim for cervical degenerative arthritis was denied.

The Board denied service connection for bilateral hearing loss and a heart disability, granted service connection for bilateral tinnitus and right knee osteochondritis dissecans, anterior cruciate ligament (ACL) tear s/p ACL reconstruction, and denied an initial rating in excess of 50 percent for posttraumatic stress disorder with generalized anxiety disorder.

The Board denied a rating greater than 70 percent for PTSD, granted an earlier effective date of August 14, 2024, for the grant of a 70 percent rating for PTSD, and denied other claims including entitlement to an effective date prior to April 3, 2025, for the grant of a 100 percent rating evaluation for CAD.

The Board remands the case to obtain a new medical opinion regarding the Veteran's ischemic heart disease, as the previous opinions were found inadequate.

The Board denied service connection for hepatitis C and remanded the claim for a heart disability due to insufficient evidence.

The Board granted service connection for headache attributed to RCVS and persistent thunderclap headache, restored a disability rating of 60 percent for asthma with COPD, denied an initial rating greater than 60 percent for asthma with COPD, denied an initial rating greater than 10 percent for RCVS and aphasia, granted separate ratings for muscle weakness in the upper and lower extremities due to RCVS, denied a higher rating for myocardial infarction with arteriosclerotic heart disease, granted TDIU from August 23, 2023, and granted an effective date of August 23, 2023, for DEA benefits.

The Board denied service connection for pneumonia and remanded the claims for iodine allergy, pilonidal cyst, sulfa allergy, heart disability, acquired psychiatric disorder, and lower and upper extremity disabilities.

The Board denied service connection for a sleep disability and a heart disability, as well as a total disability rating based on individual unemployability prior to July 28, 2022.